Kilic, Mustafa Eray https://orcid.org/0000-0002-0894-8790
Yilmaz, Mehmet Birhan https://orcid.org/0000-0002-8169-8628
Article History
Accepted: 28 November 2024
First Online: 14 December 2024
Declarations
:
: This study does not require ethical approval under the relevant local administrative regulations, and all procedures were conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: Not applicable.
: MEK declares no conflicts of interest to disclose. MBY has received institutional research fees from Bayer Healthcare Pharmaceuticals, Amgen, Novartis, Dalcor Pharmaceuticals, Novo Nordisk, AstraZeneca, and Boehringer Ingelheim.